Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy

PURPOSE: Treatment with 4 cycles of docetaxel and cyclophosphamide (TC) in the adjuvant setting is associated with better outcomes than treatment with doxorubicin and cyclophosphamide (AC). However, Western guidelines have indicated that TC confers a high risk (>20%) of febrile neutropenia (FN),...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Ye Won, Lim, Seung Taek, Gwak, Hongki, Park, Seon Young, Shin, Juhee, Han, Hye Sug, Suh, Young Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870427/
https://www.ncbi.nlm.nih.gov/pubmed/33585350
http://dx.doi.org/10.4174/astr.2021.100.2.59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870427/
https://www.ncbi.nlm.nih.gov/pubmed/33585350
http://dx.doi.org/10.4174/astr.2021.100.2.59

Ejemplares similares